IBB vs SPEM
iShares Biotechnology ETF vs SPDR Portfolio Emerging Markets ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
SPEM—
SPDR Portfolio Emerging Markets ETF
Low-cost emerging-market equity exposure.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | SPEM |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | State Street |
IBB top holdings
Holdings data unavailable for IBB.
SPEM top holdings
Holdings data unavailable for SPEM.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About SPEM
SPEM (SPDR Portfolio Emerging Markets ETF) is Low-cost emerging-market equity exposure.